Zoetis is a pure-play animal health company that develops and sells medicines, vaccines, diagnostics and related products for livestock and companion animals. Its portfolio covers cattle, swine, poultry, fish and pets, spanning preventive care, therapeutics and digital health tools for veterinarians and producers. The company operates globally with a focus on science-driven R&D and a broad direct and distributor commercial footprint.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 2,474 | — | 726 | 2% |
| Q3 2025 | 2,400 | — | 721 | 0.7% |
| Q4 2025 | 2,387 | — | 603 | -4.5% |
| Q1 2026 | 2,262 | — | 601 | -9.3% |
| Q2 2026 | 2,468 | -0.2% | 691 | -4.8% |
All markets — KeepWinning global stock screener
Other companies on NYSE: HEICO Corporation (HEI A), Mettler-Toledo International Inc. (MTD), Alcon Inc. (ALC), EMCOR Group, Inc. (EME), Venture Global, Inc. (VG), Teck Resources Limited (TECK)